drugset / Trial / NCT07605845
Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia
NaSequentialOpen-labelTreatment
Summary
The goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).
Timeline
- Start
- 2026-04-14
- Primary completion
- 2027-12-06
- Completion
- 2027-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GL-2045 | Unknown | — | Subcutaneous |